Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Walgreen Company (WAG): Barry Rosenstein, JANA Partners Increase Exposure to Their Top Holding

As a new filing with the US Securities and Exchange Commission showed, Barry Rosenstein, the manager of JANA Partners has acquired more shares of Walgreen Company (NYSE:WAG) raising his stake to 13.75 million shares. Mr. Rosenstein disclosed purchasing 1.25 million shares of Walgreen at an average price of $61.86 per share. Following the increase the investor holds around 1.43% of Walgreen Company.

Barry Rosenstein JANA PARTNERS

Mr. Rosenstein serves as a member of the board of directors of Walgreen Company (NYSE:WAG). He was appointed at the beginning of September, after JANA Partners and Walgreen entered into a Nomination and Support agreement. Mr. Rosenstein also serves on the Finance Committee of the board and was also appointed to a new strategy committee. Aside from Walgreen, the manager of JANA Partners also serves on the board of Convergys Corp (NYSE:CVG) since 2011 and on the board of Copart, Inc. (NASDAQ:CPRT). Moreover, being a big activist investor, Mr. Rosenstein sent a letter to the board of PetSmart, Inc. (NASDAQ:PETM) at the end of June asking them to reconsider the decision to conduct a recapitalization of the company.

Overall, Mr. Rosenstein’s activist hedge fund has had a good performance over the last years, returning over 20% for the last year, which was in line with other major activist hedge funds. Although, JANA Partners still underperformed in comparison with the S&P 500 Index, which gained more than 30% during 2013.

Walgreen Company (NYSE:WAG)’s stock inched up around 4% year-to-date, although the stock surged by more than 35% since the second quarter of 2013, when JANA Partners first disclosed holding a long position in the company. The investor kept his bullish sentiment on the stock, raising his exposure from around 1.31 million shares disclosed initially. Currently Walgreen Company (NYSE:WAG) represents the largest long position in JANA’s equity portfolio. Another investor that is betting big on the retail drug stores operators is Andreas Halvorsen’s Viking Global, which holds around 20.14 million shares as of the end of June, the stake amassing 6.5% of the fund’s equity portfolio, versus more than 5% in JANA’s equity portfolio.

Mr. Rosenstein increased his stake in Walgreen Company (NYSE:WAG) soon after the company declared a quarterly dividend of around $0.34 per share, which represents a 7.1% increase on the year. Moreover, at the beginning of the month, the company reported a 9.4% annual increase in its September sales, which grew to $6.48 billion.

Mr. Rosenstein’s acquisition of Walgreen Company (NYSE:WAG) shares is an interesting moves since he is not only a director, but JANA Partners is also a notorious activist fund with great returns. And since research showed that following insider trading and the moves of the greatest hedge funds can help retail investors outperform the market by a significant margin, Walgreen is worth keeping track of. Moreover, JANA Partners’ other two large long holdings, Equinix Inc (NASDAQ:EQIX) and Ashland Inc (NYSE:ASH) have also gained ground during the last year. However, Mr. Rosenstein is betting big on the market going south, since during the second quarter he boosted his ‘Put’ options in the SPDR S&P 500 ETF by over 2,000%, the position currently amassing over 14% of the equity portfolio.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!